First implantations of Biotronik wireless cardiac device go ahead
After receiving CE Mark approval last week, Biotronik, a developer of wireless remote monitoring technology for patients with cardiac devices, announced today the world’s first implantations of the new Lumax 540 implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices in 11 hospitals in seven countries.
The new Lumax 540 platform is part of Biotronik´s most technologically advanced tachycardia product portfolio, providing extended therapy options- for individualized patient device programming as well as Biotronik Home Monitoring technology for wireless remote monitoring of patient’s cardiovascular status. A comprehensive set of diagnostic capabilities are further technical advancements included on the Lumax 540 devices to help physicians identify clinically relevant atrial fibrillation and early detection of worsening heart failure status.
More info here.
